The page is the record's research on the issuer — no analyst, no rating, no view. # InMed Pharmaceuticals Inc. (NASDAQ: INM) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing InMed Pharmaceuticals Inc. is listed on NASDAQ under ticker INM, with ISIN US4576377000. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-A1. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is British Columbia, Canada. The segment is not on the record. The issuer is listed and not halted. ## The disclosure read The record holds 76 filings across 47 filing days in the twelve months to 2026-11-08. The median gap between filing days is 4.5 days. The latest filing is dated 2026-11-05, which is 3 days before the record date, and is of type agm_egm. The exchange median is 6.0 days for cadence, 52 filings and 5.0 days for latency across 4,359 issuers. The sector median is 6.0 days for cadence, 63.0 filings and 4.0 days for latency across 526 issuers. ## Auditor The auditor of record is CBIZ CPAs P.C., located in New York, NY. The record shows no auditor changes. ## Events and halts The record shows no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is not set. ## Orderability The outcome is not determinable, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer is held in sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001728328.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/INM (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1728328/000121390026098419/ea0301263-10k_inmed.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/INM (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/INM · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp